Moberg Pharma granted U.S. patent relating to improved dosing of MOB-015

The Quick Take
STOCKHOLM, Nov. 3, 2026 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) today announced that the United States Patent and Trademark Office (USPTO) has granted a patent relating to an improved dosing regimen for MOB-015, the company's topical drug for onychomycosis. The U.S. is the first...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Cash Rate Rise Squeezes Small Businesses With Little Buffer - Mirage News
Cash Rate Rise Squeezes Small Businesses With Little Buffer Mirage News
Business
L'IA aux yeux bandés : pourquoi l'IA échoue en l'absence de contexte d'entreprise, et comment StackRails y remédie
DUBLIN, 3 novembre 2026 /PRNewswire/ -- « Nos ingénieurs repoussent chaque jour les limites du codage par IA sur des bases de code vastes et complexes. Nous…
Business
Blindfolded AI: Why AI Fails Without Enterprise Context, and How StackRails Solves It
DUBLIN, Nov. 3, 2026 /PRNewswire/ -- "Our engineers push AI coding to its limits every day, on large and complex codebases. We adopted AI earlier than most,…
Business
Multiconsult third quarter 2026 results
OSLO, Norway, Nov. 3, 2026 /PRNewswire/ -- Multiconsult's performance gradually improved towards the end of the quarter, reflecting early effects of measures…
